Correlation between initial alkaline phosphatase levels and overall survival in newly diagnosed multiple myeloma patients
- Jie Tan 1,2, Jun-Peng Liu 3, Xing-Chen Yao 3, Zi-Yu Xu 3, Yue Wu 3, Xiang-Jun Shi 4, Ming Shi 3, Meng Li 3, Xin-Ru Du 3
- Jie Tan 1,2, Jun-Peng Liu 3, Xing-Chen Yao 3
- 1Department of Hematology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.
- 2Department of General Practice, Liyuan Community Health Service Center, Beijing, China.
- 3Department of Orthopaedic Surgery, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.
- 4Department of Rheumatism, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
- 0Department of Hematology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Alkaline phosphatase (ALP) levels in multiple myeloma (MM) patients correlate with survival outcomes. An ALP range of 70 to <120 U/L is associated with better prognosis in newly diagnosed MM patients.
Area Of Science
- Hematology
- Oncology
- Biochemistry
Background
- Alkaline phosphatase (ALP) is a marker that may reflect multiple myeloma (MM) patient status.
- The precise relationship between ALP and MM prognosis remains unclear.
- This study investigates the association between initial ALP levels and overall survival in newly diagnosed MM patients.
Purpose Of The Study
- To determine the association between initial alkaline phosphatase (ALP) levels and overall survival in newly diagnosed multiple myeloma (MM) patients.
- To identify optimal ALP cut-off values for prognostic stratification.
- To explore the correlation of ALP with other clinical and biochemical markers in MM.
Main Methods
- Retrospective analysis of clinical data from 202 newly diagnosed MM patients.
- Patients categorized into three groups based on ALP levels: <70 U/L, 70 to <120 U/L, and ≥120 U/L.
- COX regression analysis used to identify independent risk factors for survival.
Main Results
- Significant differences in survival, liver function, and bone disease markers were observed across ALP groups (P<0.05).
- Median survival was 25, 52, and 31 months for ALP groups <70, 70-<120, and ≥120 U/L, respectively.
- Patients with ALP 70 to <120 U/L showed significantly higher 3-year survival (P=0.006).
- Independent prognostic factors included age, ISS stage, AST, β2-microglobulin, ALP grade, and severe bone disease.
Conclusions
- Initial alkaline phosphatase (ALP) levels are significantly correlated with the prognosis of multiple myeloma (MM) patients.
- An ALP range of 70 to <120 U/L is associated with a better survival expectation in newly diagnosed MM.
- ALP stratification can aid in risk assessment and treatment planning for MM patients.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.

